Complete Pathological Response after Sequential Therapy with Sunitinib and Radiotherapy for Metastatic Clear Cell Renal Carcinoma

作者: Eric Lechevallier , Sebastien Salas , Jean-Laurent Deville , Alexandre Rochwerger , Geoffroy Venton

DOI:

关键词: Bone metastasisPathological responseOncologyPathologicalSunitinibMedicineClear Cell Renal CarcinomaNephrectomyRadiation therapyRadical surgeryUrologyInternal medicine

摘要: Despite great improvements in the management of metastatic clear cell renal carcinoma, complete responses with antiangiogenic therapies are infrequent and pathological remain anecdotal. We report response a solitary bone metastasis from carcinoma after sequential treatment sunitinib radiotherapy. In February 2009, female patient was diagnosed left kidney, bearing only one site localized proximal extremity tibia. Radical nephrectomy performed at first. Thereafter, administered standard dose level for four weeks followed by two free each cycle. The underwent palliative radiotherapy between fifth sixth Due to stable status, radical surgery knee then analysis concluded response. This case highlights potential synergy radiation therapy carcinoma. Antiangiogenic targeted have demonstrated

参考文章(26)
Daniel Taussky, Denis Soulières, Hypofractionated radiotherapy with concomitant sunitinib - is there a radiosensitizing effect? Canadian Journal of Urology. ,vol. 16, pp. 4599- ,(2009)
Axel Bex, Astrid A. M. van der Veldt, Christian Blank, Alfons J. M. van den Eertwegh, Epie Boven, Simon Horenblas, John Haanen, Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery World Journal of Urology. ,vol. 27, pp. 533- 539 ,(2009) , 10.1007/S00345-008-0368-7
Rodney H Breau, Michael L Blute, Surgery for renal cell carcinoma metastases. Current Opinion in Urology. ,vol. 20, pp. 375- 381 ,(2010) , 10.1097/MOU.0B013E32833C7ADA
Nicholas J. Hellenthal, Willie Underwood, Remedios Penetrante, Alan Litwin, Shaozeng Zhang, Gregory E. Wilding, Bin T. Teh, Hyung L. Kim, Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma Journal of Urology. ,vol. 184, pp. 859- 864 ,(2010) , 10.1016/J.JURO.2010.05.041
Astrid A.M. van der Veldt, Martijn R. Meijerink, Alfons J.M. van den Eertwegh, Axel Bex, Gijsbert de Gast, John B.A.G. Haanen, Epie Boven, Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response Clinical Cancer Research. ,vol. 14, pp. 2431- 2436 ,(2008) , 10.1158/1078-0432.CCR-07-4089
Lauren C. Harshman, R. James Yu, Genevera I. Allen, Sandy Srinivas, Harcharan S. Gill, Benjamin I. Chung, Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC) Urologic Oncology: Seminars and Original Investigations. ,vol. 31, pp. 379- 385 ,(2013) , 10.1016/J.UROLONC.2011.01.005
Bernard Escudier, Tim Eisen, Walter M Stadler, Cezary Szczylik, Stéphane Oudard, Michael Siebels, Sylvie Negrier, Christine Chevreau, Ewa Solska, Apurva A Desai, Frédéric Rolland, Tomasz Demkow, Thomas E Hutson, Martin Gore, Scott Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M Bukowski, None, Sorafenib in advanced clear-cell renal-cell carcinoma. The New England Journal of Medicine. ,vol. 356, pp. 125- 134 ,(2007) , 10.1056/NEJMOA060655
Youlia M. Kirova, Vincent Servois, Cyrus Chargari, Malika Amessis, Marc Zerbib, Philippe Beuzeboc, Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapy Investigational New Drugs. ,vol. 30, pp. 1241- 1243 ,(2012) , 10.1007/S10637-010-9613-1
Paul Russo, Multi-modal treatment for metastatic renal cancer: the role of surgery World Journal of Urology. ,vol. 28, pp. 295- 301 ,(2010) , 10.1007/S00345-010-0530-X
Mohit Kasibhatla, Peter Steinberg, Jeffrey Meyer, Marc S. Ernstoff, Daniel J. George, Radiation therapy and sorafenib: Clinical data and rationale for the combination in metastatic renal cell carcinoma Clinical Genitourinary Cancer. ,vol. 5, pp. 291- 294 ,(2007) , 10.3816/CGC.2007.N.007